Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2024 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call. I would now like to turn the meeting over to Ms. Juli Miller.

Related Keywords

,Philip Leider ,Gavin Wood ,Peter Lawson ,John Lunger ,Cintia Piccina ,Marc Frahm ,Jonathan Chang ,Mihaela Druta ,Juli Miller ,Dennis Williams ,Adrian Rawcliffe ,Sandra Dangelo ,Michael Schmidt ,Rodman Renshaw ,Tony Butler ,Graig Suvannavejh ,Sarcoma Alliance ,Adaptimmune Therapeutics Plc ,Genentech ,Navy Yard ,Nasdaq ,Head Of Late Stage Development ,Barclays ,Adaptimmune Therapeutics ,Call Transcript May ,Business Update Conference ,Chief Executive Officer ,Investor Day ,Late Stage Development ,Chief Commercial Officer ,Patient Advocate ,Hercules Capital ,Chief Financial Officer ,